Left Ventricular Systolic Dysfunction
35
5
6
17
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.9%
1 terminated out of 35 trials
94.4%
+7.9% vs benchmark
23%
8 trials in Phase 3/4
24%
4 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (35)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure
Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation
Ertugliflozin for Functional Mitral Regurgitation
Hyperkalaemia and Its Impact on Therapy with RAASi
The SMART-LV Pilot Study
Early Evaluation of Left Ventricular Systolic Function Impairment in Patients With Chronic Kidney Disease by Multimodal Ultrasonography
The Relationship Between Inflammatory ARTritis and CArdiac DIseAse
AI-ECG Screening for Left Ventricular Systolic Dysfunction
A Study to Evaluate Accuracy and Validity of the "Chang Gung" Ventricular Systolic Dysfunction Screening Software
Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
Mechanisms and Innovations in Cardiac Resynchronisation Therapy
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.
Simplified Assessment of Left Ventricular Systolic Function in Septic Shock Patients
Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN
Heart Rate Response to Regadenoson and Sudden Cardiac Death